Talecris Biotherapeutics and NC Gov Bev Perdue have reported that the company will expand its manufacturing facilities in Clayton, creating 259 new jobs over the next seven years. The company plans to spend $268.7m to expand their facilities in Clayton. State and local tax credits and incentive grants will be provided to facilitate the expansion.
Talecris currently employs approximately 4,700 people worldwide and is headquartered in the biotechnology hub of Research Triangle Park, NC.
The Clayton manufacturing facility produces protein therapies that are used to treat a range of diseases, including immune deficiencies, hemophilia, genetic emphysema, and a rare neurological disorder known as chronic inflammatory demyelinating polyneuropathy (CIDP).
To facilitate Talecris’ manufacturing expansion, the state has awarded the company a $250,000 grant from the state’s One North Carolina Fund.
Mary Kuhn, executive vice president of operations at Talecris, said: “We’re extremely pleased to be investing in our company’s growth while at the same time contributing to the economic prosperity of Johnston County, a region that has been a historic partner in the development of our industry.
“Our manufacturing capabilities have grown exponentially in recent years, creating more jobs and local opportunities. We’re excited to continue expanding our business in a region that has been so supportive of the biotechnology industry.”
Perdue said: “The competition for these types of jobs is fierce. The fact that Talecris has found the tools it needs to succeed in North Carolina demonstrates why this state’s business climate is consistently named as the best in the nation.”